Featured ArticlesJDD HighlightsLatest News

JDD April 2026 Highlights and Editor Picks

By April 10, 2026No Comments

Curated by the JDD Editors

Missed any of our April highlights? April is our immunodermatology issue and is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated roundup from the JDD Editors. This is your guide to must-read articles for the derm community.

APRIL ISSUE

Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions provides findings that demonstrate clinical efficacy for the treatment of CSU with an acceptable safety profile.

Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review aims to characterize the study populations of clinical trials for JKIs for dermatologic indications.

Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders evaluates the ability of widely available Vision Language Models (VLMs), ChatGPT-3.5, ChatGPT-4o, and Google Gemini, in diagnosing common nail disorders using clinical images.

Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations  aims to offer an updated review on best practices for depigmenting treatment protocols and highlight ongoing debates on dermatologic safety and efficacy

Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis evaluates geographic variation in patient interest in dermatology services and compares it to dermatologist supply to identify areas of potential unmet need.

Exosome-Based Therapies in Dermatology: A Scoping Review summarizes clinical studies evaluating exosome-based dermatologic therapies, clarifying evidence, safety, and regulatory context.

Beyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis compares the efficacy, tolerability, and cosmetic benefits of 0.6% micronized selenium disulfide shampoo (SeS2) to 2% ketoconazole shampoo.

Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis evaluates geographic variation in patient interest in dermatology services and compares it to dermatologist supply to identify areas of potential unmet need.